This range is monitored on a regular basis in a timeframe between 3 and 28 days, depending on their individual stability. The dosing scheme of the medication is adapted depending on the result of a blood analysis (INR) and historical medical data.

This blood analysis is performed in one of two possible ways:

1. Within a laboratorium (for ‘regular patients’)
2. By a self measurement handheld device at home (for ‘self measurement patients’).

Objective criteria are defined by the FNT to select patients for self-measurement. These patients are trained at the TTCA to teach them the necessary skills. An Internet based e-learning module supports part of this training.

aktuell 20. Mai 2005: gewinnt den ersten Preis on the ICT AWARD 2005! IMO und Portavita stellen eTTCA am 2. Juni 2005 vor: The ICMCC Event 2005. June 1-3, 2005. NCC The Hague, The Netherlands. www.icmcc2005.com. Weitere Informationen: www.thrombosedienst.de Informationen: info@thrombosedienst.de